Lobbying Relationship

Client

AMGEN, INC

More records

Lobbying firm

Nossaman LLP (Formerly Nossaman LLP/O'Connor & Hannan)

More records

  • Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Reconciliation Act of 2010 (End Stage Renal Disease).

Duration: to

General Issues: Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark, Taxation/Internal Revenue Code

Spending: about $410,000 (But it's complicated. Here's why.)

Agencies lobbied since 2008: House of Representatives, U.S. Senate,, U.S. Senate

Bills mentioned

S.1679: Affordable Health Choices Act

Sponsor: Tom Harkin (D-Iowa)

H.R.3590: Patient Protection and Affordable Care Act

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4872: Health Care and Education Reconciliation Act of 2010

Sponsor: John M. Spratt Jr. (D-S.C.)

S.1769: Options for Investors through United States Certified Coins Act of 2009

Sponsor: David Vitter (R-La.)

H.R.1548: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Brent Heberlee Legislative Director, Rep. James Bilbray Legislative Assistant, Senator Richard Bryan Legislative Director, Senator Richard Bryan
Sherry Harper Legislative Director, Congressman Ron Kind
Roy Coffee n/a
Timothy W. Jenkins n/a
FREDERICK T. DOMBO n/a
B. Keith Heard n/a
DANIELLE FAGRE n/a
Patrick O'Donnell n/a
Timothy Jenkins n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Registration
Termination
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page